Comparison of Skin and Blood Disease Burden in Patients with Cutaneous T-Cell Lymphoma

Background/Objectives: Total body surface area (T) and blood (B) staging for cutaneous T-cell lymphoma (CTCL) are associated with disease progression and survival rates. However, the quantitative relationship between skin and blood disease burden in CTCL remains understudied. Methods: This retrospective study assesses total body surface area (TBSA) compared with several quantitative flow cytometry metrics and peripheral blood morphology in 322 patients from 1 January 2012, to 31 December 2021. Sub-analyses also compare the estimated marginal mean TBSA between B stages; between qualitative determinations of blood abnormality by flow cytometry; and between qualitative determinations of blood abnormality by peripheral blood morphology. Lastly, we analyze the association between blood staging by 2007 and 2022 criteria. Results: All possible combinations of T and B stages were represented in the cohort, except for T0-B2. TBSA was significantly but weakly associated with all flow cytometry and peripheral blood morphology metrics except the CD4:CD8 ratio. The estimated marginal mean TBSA was higher for B2 and B1 than the B0 stage but did not differ significantly between B2 and B1. The estimated marginal mean TBSA was higher for positive than for equivocal or negative qualitative determinations of blood disease burden by both flow cytometry and peripheral blood morphology. Comparing the 2007 and 2022 blood-staging flow cytometry criteria demonstrated only moderate correlation between the two classification criteria. Conclusions: The limited association of TBSA with blood disease burden underscores the importance of assessing both skin and blood disease burden in patients being evaluated for CTCL to ensure accurate staging and prognostication.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-18
DOI
https://doi.org/10.3390/cancers18223685
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparison of Skin and Blood Disease Burden in Patients with Cutaneous T-Cell Lymphoma

Lucy Fu, Kristy Lucile Wolniak, Joan Guitart, Payton Fors Trimark
1 links
Cancers
Cutaneous lymphoproliferative disorders research
article

Comparison of Skin and Blood Disease Burden in Patients with Cutaneous T-Cell Lymphoma

Lucy Fu, Kristy Lucile Wolniak, Joan Guitart, Payton Fors Trimark
article en

Abstract

Background/Objectives: Total body surface area (T) and blood (B) staging for cutaneous T-cell lymphoma (CTCL) are associated with disease progression and survival rates. However, the quantitative relationship between skin and blood disease burden in CTCL remains understudied. Methods: This retrospective study assesses total body surface area (TBSA) compared with several quantitative flow cytometry metrics and peripheral blood morphology in 322 patients from 1 January 2012, to 31 December 2021. Sub-analyses also compare the estimated marginal mean TBSA between B stages; between qualitative determinations of blood abnormality by flow cytometry; and between qualitative determinations of blood abnormality by peripheral blood morphology. Lastly, we analyze the association between blood staging by 2007 and 2022 criteria. Results: All possible combinations of T and B stages were represented in the cohort, except for T0-B2. TBSA was significantly but weakly associated with all flow cytometry and peripheral blood morphology metrics except the CD4:CD8 ratio. The estimated marginal mean TBSA was higher for B2 and B1 than the B0 stage but did not differ significantly between B2 and B1. The estimated marginal mean TBSA was higher for positive than for equivocal or negative qualitative determinations of blood disease burden by both flow cytometry and peripheral blood morphology. Comparing the 2007 and 2022 blood-staging flow cytometry criteria demonstrated only moderate correlation between the two classification criteria. Conclusions: The limited association of TBSA with blood disease burden underscores the importance of assessing both skin and blood disease burden in patients being evaluated for CTCL to ensure accurate staging and prognostication.

CancersVol. 18(22)
Northwestern University (US), Northwestern Memorial Hospital (US)
Good health and well-being
Cutaneous lymphoproliferative disorders research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon